---
title: "NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study | NGEN Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287625578.md"
description: "NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study | NGEN Stock News"
datetime: "2026-05-26T03:15:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287625578.md)
  - [en](https://longbridge.com/en/news/287625578.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287625578.md)
---

# NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study | NGEN Stock News

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study | NGEN Stock News

### Related Stocks

- [NGEN.US](https://longbridge.com/en/quote/NGEN.US.md)

## Related News & Research

- [NervGen Prices $60 Mln Offering Of Shares And Warrants To Advance NVG-291; Stock Down](https://longbridge.com/en/news/287319498.md)
- [NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan](https://longbridge.com/en/news/284280997.md)
- [Shelby Yohn resigns as CFO of SCI; Jerry Blaskie engaged as consulting CFO](https://longbridge.com/en/news/295795218.md)
- [FIGR: Record volume, margin expansion, and partner growth position the business for accelerated scaling](https://longbridge.com/en/news/295816686.md)
- [08:39 ETFintel Connect Releases 2026 Cost Per Acquisition Guide to Affiliate Customer Growth in Financial Services](https://longbridge.com/en/news/295666920.md)